As we know, activation of CB1 and CB2 receptors by cannabinoids has been shown to inhibit the PI3K/Akt/mTOR pathway in glioblastoma cells, leading to a decrease in cell proliferation and an increase in apoptosis and autophagy (Quigley et al., 2009). This evidence concerns the gene CNR1 and glioblastoma.